Baher Matta Hanna
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Baher Matta Hanna has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Sonia Ali El-Saiedi
Department of Pediatrics, Faculty of Medicine, Cairo University, Egypt
3 shared publications Sonia A. El-Saiedi
Department of Pediatrics, Cairo University
2 shared publicationsAmmal Mahmoud El‐Sisi
Division of Pediatric Cardiology, Department of Pediatrics, Cairo University, Cairo, Egypt
1 shared publication- Ashraf Abd El Reheem
Anaesthesia Department, Cairo University, Giza, Egypt
1 shared publication Ashraf AbdElRahim
Department of Anesthesia, Cairo University
1 shared publication- Aya Mohammed Fattouh
Department of Pediatrics, Cairo University, Cairo, Egypt
1 shared publication
Latest Publications
- Open Access
- 1 February 2023
- Published by Hindawi Limited in Journal of Interventional Cardiology
- Vol. 2023, 1-8
Staged Percutaneous Management of Pulmonary Atresia and Intact Interventricular Septum: Stretching the Limits
Aims. Pulmonary atresia with intact ventricular septum (PA/IVS) can be treated by catheter-based interventions and complemented by various surgical procedures. We aim to determine a long-term treatment strategy to enable patients to be surgery free, depending solely on percutaneous interventions. Methods and Results. We selected five patients from among a cohort of patients with PA/IVS treated at birth with radiofrequency perforation and dilatation of the pulmonary valve. Patients had reached a pulmonary valve annulus of 20mm or larger on their biannual echocardiographic follow-up, with right ventricular dilatation. The findings, together with the right ventricular outflow tract and pulmonary arterial tree, were confirmed by multislice computerised tomography. Based on the angiographic size of the pulmonary valve annulus, all patients were successfully implanted with either Melody® or Edwards® pulmonary valves percutaneously, regardless of their small weights and ages. No complications were encountered. Conclusion. We managed to stretch the age and weight limitations for performing percutaneous pulmonary valve implantation (PPVI): interventions were attempted whenever a pulmonary annulus size of >20mm was reached, which was rationalised by the prevention of progressive right ventricular outflow tract dilatation and accommodating valves between 24 and 26mm, which is enough to sustain a normal pulmonary flow in adulthood.
- 1 February 2023
- Published by Hindawi Limited in Journal of Interventional Cardiology
- Vol. 2023, 1-8
Open AccessStaged Percutaneous Management of Pulmonary Atresia and Intact Interventricular Septum: Stretching the Limits
Aims. Pulmonary atresia with intact ventricular septum (PA/IVS) can be treated by catheter-based interventions and complemented by various surgical procedures. We aim to determine a long-term treatment strategy to enable patients to be surgery free, depending solely on percutaneous interventions. Methods and Results. We selected five patients from among a cohort of patients with PA/IVS treated at birth with radiofrequency perforation and dilatation of the pulmonary valve. Patients had reached a pulmonary valve annulus of 20mm or larger on their biannual echocardiographic follow-up, with right ventricular dilatation. The findings, together with the right ventricular outflow tract and pulmonary arterial tree, were confirmed by multislice computerised tomography. Based on the angiographic size of the pulmonary valve annulus, all patients were successfully implanted with either Melody® or Edwards® pulmonary valves percutaneously, regardless of their small weights and ages. No complications were encountered. Conclusion. We managed to stretch the age and weight limitations for performing percutaneous pulmonary valve implantation (PPVI): interventions were attempted whenever a pulmonary annulus size of >20mm was reached, which was rationalised by the prevention of progressive right ventricular outflow tract dilatation and accommodating valves between 24 and 26mm, which is enough to sustain a normal pulmonary flow in adulthood.
- Open Access
- 27 December 2022
- Published by Egyptian Knowledge Bank in Pediatric Sciences Journal
- Vol. 3 (1) , 38-43
Children Surviving Post-Univentricular Repair: Single Center Experience
Background: The children population who underwent single ventricle repair is growing in number with longer follow up periods and increased frequency of complications. Aim of work: To evaluate the outcome and complications post Glenn and Fontan single ventricle repair in children. Material and Methods: A retrospective study of data within files of all surviving patients post univentricular surgical repair, who were following up at Post Cardiac Interventions Clinic in Cairo University Children Hospital from October 2007 until October 2020. Results: The files of 113 patients were enrolled in the study, 93 (82.3%) of them were post Glenn operation. Their mean± SD age at the time of the operation was 1.4± 0.9years, and mean follow up duration of 8.3 ±3 years. The study included 20 (17.7%) patients post Fontan operation, with a mean age at the time of the operation of 7.82± 1.63years, and mean follow up duration of 4.75 ±0.08 years. They were 77 (68.15%) males, and 36(31.85%) females. Complications post Glenn operation were heart failure in 34(36.5%) patients, pericardial and pleural effusion in 4 (4.3%) and hypoalbuminemia in 2 (2.15%). Complications post Fontan were heart failure in 4 (20%) patients, arrhythmia in 2 (10%), and protein losing enteropathy in 2 (10%). Frequency of complications was not related to the age at the time of the Glenn and Fontan operation (p =0.793) and (p=0.079) respectively. Conclusion: Performing Glenn and Fontan at older age was not related to the frequency of complications in our patients. Heart failure was the most common complication post Glenn and Fontan operations.
- 27 December 2022
- Published by Egyptian Knowledge Bank in Pediatric Sciences Journal
- Vol. 3 (1) , 38-43
Open AccessChildren Surviving Post-Univentricular Repair: Single Center Experience
Background: The children population who underwent single ventricle repair is growing in number with longer follow up periods and increased frequency of complications. Aim of work: To evaluate the outcome and complications post Glenn and Fontan single ventricle repair in children. Material and Methods: A retrospective study of data within files of all surviving patients post univentricular surgical repair, who were following up at Post Cardiac Interventions Clinic in Cairo University Children Hospital from October 2007 until October 2020. Results: The files of 113 patients were enrolled in the study, 93 (82.3%) of them were post Glenn operation. Their mean± SD age at the time of the operation was 1.4± 0.9years, and mean follow up duration of 8.3 ±3 years. The study included 20 (17.7%) patients post Fontan operation, with a mean age at the time of the operation of 7.82± 1.63years, and mean follow up duration of 4.75 ±0.08 years. They were 77 (68.15%) males, and 36(31.85%) females. Complications post Glenn operation were heart failure in 34(36.5%) patients, pericardial and pleural effusion in 4 (4.3%) and hypoalbuminemia in 2 (2.15%). Complications post Fontan were heart failure in 4 (20%) patients, arrhythmia in 2 (10%), and protein losing enteropathy in 2 (10%). Frequency of complications was not related to the age at the time of the Glenn and Fontan operation (p =0.793) and (p=0.079) respectively. Conclusion: Performing Glenn and Fontan at older age was not related to the frequency of complications in our patients. Heart failure was the most common complication post Glenn and Fontan operations.
- Open Access
- 18 June 2022
- Published by Saudi Heart Association in Journal of the Saudi Heart Association
- Vol. 34 (1) , 40-51
Outcome predictors in catheter interventions for severe right ventricular outflow tract obstructions
Introduction & Aim of Work: Transcatheter treatment for critical pulmonary stenosis and membranous pulmonary atresia has become the gold standard of care in many centers. We aimed at evaluating the predictors of outcome in interventions for treatment of duct-dependent right ventricular outflow tract obstruction with intact interventricular septum. Subjects & Methods: 68 cases with pulmonary atresia with intact interventricular septum (PA/IVS) and 50 cases with critical pulmonary stenosis (CPS), all younger than 3 months of age, were operated during the period of 10 years; excluding patients with tricuspid valve annulus Z-score smaller than -4, evidence of right ventricular-dependent coronary circulation or additional malformations. Results: Age, weight, body surface area as well as tricuspid & pulmonary valve Z-scores were significantly less in PA/IVS; right ventricular pressure was similar in both groups however procedural success and survival to hospital discharge was higher in the CPS group. Lower age, weight and body surface area were associated with procedural failure. Weight was the only predictor of procedural success; while weight and lower post-procedural right ventricular pressure were independent predictors for survival to hospital discharge. Post-procedural right ventricular pressure and length of stay were less in the CPS group. tricuspid and pulmonary valve annulus Z-scores were the only independent predictors of the post-procedural milrinone duration in PA/IVS. Conclusion: We advocate for the use of larger balloon/pulmonary annulus ratio, to achieve a lower right ventricular pressure not fearing excessive pulmonary regurgitation that might be beneficial for right ventricular growth; and for the combination with ductal stenting in borderline or bipartite right ventricles.
- 18 June 2022
- Published by Saudi Heart Association in Journal of the Saudi Heart Association
- Vol. 34 (1) , 40-51
Open AccessOutcome predictors in catheter interventions for severe right ventricular outflow tract obstructions
Introduction & Aim of Work: Transcatheter treatment for critical pulmonary stenosis and membranous pulmonary atresia has become the gold standard of care in many centers. We aimed at evaluating the predictors of outcome in interventions for treatment of duct-dependent right ventricular outflow tract obstruction with intact interventricular septum. Subjects & Methods: 68 cases with pulmonary atresia with intact interventricular septum (PA/IVS) and 50 cases with critical pulmonary stenosis (CPS), all younger than 3 months of age, were operated during the period of 10 years; excluding patients with tricuspid valve annulus Z-score smaller than -4, evidence of right ventricular-dependent coronary circulation or additional malformations. Results: Age, weight, body surface area as well as tricuspid & pulmonary valve Z-scores were significantly less in PA/IVS; right ventricular pressure was similar in both groups however procedural success and survival to hospital discharge was higher in the CPS group. Lower age, weight and body surface area were associated with procedural failure. Weight was the only predictor of procedural success; while weight and lower post-procedural right ventricular pressure were independent predictors for survival to hospital discharge. Post-procedural right ventricular pressure and length of stay were less in the CPS group. tricuspid and pulmonary valve annulus Z-scores were the only independent predictors of the post-procedural milrinone duration in PA/IVS. Conclusion: We advocate for the use of larger balloon/pulmonary annulus ratio, to achieve a lower right ventricular pressure not fearing excessive pulmonary regurgitation that might be beneficial for right ventricular growth; and for the combination with ductal stenting in borderline or bipartite right ventricles.
- 1 July 2021
- Published by Egyptian Knowledge Bank in Pediatric Sciences Journal
- Vol. 1 (2) , 62-70
Effectiveness and Dose of Carvedilol Therapy In Children with Dilated Cardiomyopathy: A Prospective Randomized Double-Blinded Trial
Background: The efficacy and safety of the beta blocker carvedilol in pediatric patients with chronic heart failure (CHF) has not been fully established till now. Aim of the Work: To assess the role of carvedilol in the treatment of children with dilated cardiomyopathy, to demonstrate its efficacy, tolerability and determine the least effective dose. Patients and Methods: We conducted a double-blind, placebo-controlled study of 53 children with dilated cardiomyopathy. Patients were randomly assigned to receive either placebo (26 patients) or carvedilol (27 patients) added to the standard CHF therapy that consists of angiotensin-converting-enzyme inhibitor and diuretics. The carvedilol group was further subdivided into 2 groups according to the received dose of carvedilol. Subgroup I (11 cases) received carvedilol dose of 0.01-0.09 mg/kg/day and subgroup II (16 cases) received carvedilol with dose increments every 2 weeks from 0.01-0.2 mg/kg/day. All patients were followed up for four months after reaching the target dose. Results: The end results of the study showed that there was a significant improvement in Ross heart failure class, fractional shortening (FS), left ventricle end systolic dimension (LVESD) and left ventricle end diastolic dimension (LVEDD) in patients of the study group which was not achieved in the control group. On the other hand there was no statistically significant difference between sub groups I and II regarding the end point. Carvidolol was well tolerated, with no side effects or drug interaction reported. Conclusion: Addition of carvedilol to standard anti-failure therapy is of beneficial effect and is well tolerated in children with CHF on top of DCM. There may be no need for carvedilol dose up- titration at least for the first months of treatment.
- 1 July 2021
- Published by Egyptian Knowledge Bank in Pediatric Sciences Journal
- Vol. 1 (2) , 62-70
Effectiveness and Dose of Carvedilol Therapy In Children with Dilated Cardiomyopathy: A Prospective Randomized Double-Blinded Trial
Background: The efficacy and safety of the beta blocker carvedilol in pediatric patients with chronic heart failure (CHF) has not been fully established till now. Aim of the Work: To assess the role of carvedilol in the treatment of children with dilated cardiomyopathy, to demonstrate its efficacy, tolerability and determine the least effective dose. Patients and Methods: We conducted a double-blind, placebo-controlled study of 53 children with dilated cardiomyopathy. Patients were randomly assigned to receive either placebo (26 patients) or carvedilol (27 patients) added to the standard CHF therapy that consists of angiotensin-converting-enzyme inhibitor and diuretics. The carvedilol group was further subdivided into 2 groups according to the received dose of carvedilol. Subgroup I (11 cases) received carvedilol dose of 0.01-0.09 mg/kg/day and subgroup II (16 cases) received carvedilol with dose increments every 2 weeks from 0.01-0.2 mg/kg/day. All patients were followed up for four months after reaching the target dose. Results: The end results of the study showed that there was a significant improvement in Ross heart failure class, fractional shortening (FS), left ventricle end systolic dimension (LVESD) and left ventricle end diastolic dimension (LVEDD) in patients of the study group which was not achieved in the control group. On the other hand there was no statistically significant difference between sub groups I and II regarding the end point. Carvidolol was well tolerated, with no side effects or drug interaction reported. Conclusion: Addition of carvedilol to standard anti-failure therapy is of beneficial effect and is well tolerated in children with CHF on top of DCM. There may be no need for carvedilol dose up- titration at least for the first months of treatment.
- 1 July 2021
- Published by Egyptian Knowledge Bank in Pediatric Sciences Journal
- Vol. 1 (2) , 41-51
Echocardiographic Parameters of Severity in Isolated Neonatal Patent Ductus Arteriosus
Background: A hemodynamically-significant patent ductus arteriosus (hsPDA) compromises the early neonatal transition. There is no general agreement on echocardiographic indicators of hsPDA that can predict clinical decompensation. Aim of the Work: We aimed to assess echocardiographic parameters that are associated with the isolated PDA effects on hemodynamics, which could help in subsequent management decision making. Materials and Methods: We conducted a prospective observational analytical study on 50 neonates with isolated PDA and 20 controls. They underwent clinical and echocardiographic assessment at 48 hours of age, after another 48-72 hours and prior to discharge. Results: No correlation was found between PDA diameter and weight (p=0.72), length (p=0.11), Body surface area (BSA) (p=0.33), gestational age (p=0.13). A strong association of PDA-related hemodynamic instability was found with pulmonary hypertension (p= Conclusion: Pulmonary hypertension, larger LA Z-score and LPA Z-scores are important early (at 48 hours) associations of a hsPDA and hemodynamic instability.
- 1 July 2021
- Published by Egyptian Knowledge Bank in Pediatric Sciences Journal
- Vol. 1 (2) , 41-51
Echocardiographic Parameters of Severity in Isolated Neonatal Patent Ductus Arteriosus
Background: A hemodynamically-significant patent ductus arteriosus (hsPDA) compromises the early neonatal transition. There is no general agreement on echocardiographic indicators of hsPDA that can predict clinical decompensation. Aim of the Work: We aimed to assess echocardiographic parameters that are associated with the isolated PDA effects on hemodynamics, which could help in subsequent management decision making. Materials and Methods: We conducted a prospective observational analytical study on 50 neonates with isolated PDA and 20 controls. They underwent clinical and echocardiographic assessment at 48 hours of age, after another 48-72 hours and prior to discharge. Results: No correlation was found between PDA diameter and weight (p=0.72), length (p=0.11), Body surface area (BSA) (p=0.33), gestational age (p=0.13). A strong association of PDA-related hemodynamic instability was found with pulmonary hypertension (p= Conclusion: Pulmonary hypertension, larger LA Z-score and LPA Z-scores are important early (at 48 hours) associations of a hsPDA and hemodynamic instability.
- 31 May 2021
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 32 (1) , 60-63
Rheology of right ventricular outflow tract obstruction: sub-pulmonary membrane developing months after primary intervention to treat pulmonary atresia with intact interventricular septum
Isolated sub-pulmonary membrane is a rare condition, the origin of which has been debatable. Transcatheter treatment of pulmonary valve atresia with intact interventricular septum by radiofrequency perforation and balloon dilatation to restore biventricular circulation is gaining more popularity, with improving results over time. We report in our experience of 79 cases in 10 years the development of a sub-pulmonary membrane in 4 cases: causing significant obstruction requiring surgical excision in one case that revealed a fibrous membrane on pathology; causing mild right ventricular outflow tract obstruction in another and not yet causing obstruction in 2. On cardiac MRI, the right ventricular outflow tract and the right ventricular outflow tract/pulmonary atresia angle showed no morphological abnormalities.
- 31 May 2021
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 32 (1) , 60-63
Rheology of right ventricular outflow tract obstruction: sub-pulmonary membrane developing months after primary intervention to treat pulmonary atresia with intact interventricular septum
Isolated sub-pulmonary membrane is a rare condition, the origin of which has been debatable. Transcatheter treatment of pulmonary valve atresia with intact interventricular septum by radiofrequency perforation and balloon dilatation to restore biventricular circulation is gaining more popularity, with improving results over time. We report in our experience of 79 cases in 10 years the development of a sub-pulmonary membrane in 4 cases: causing significant obstruction requiring surgical excision in one case that revealed a fibrous membrane on pathology; causing mild right ventricular outflow tract obstruction in another and not yet causing obstruction in 2. On cardiac MRI, the right ventricular outflow tract and the right ventricular outflow tract/pulmonary atresia angle showed no morphological abnormalities.
- Open Access
- 15 June 2020
- Published by Elsevier in JACC: Case Reports
- Vol. 2 (9) , 1411-1413
The Hidden Victims of the COVID-19 Pandemic
- 15 June 2020
- Published by Elsevier in JACC: Case Reports
- Vol. 2 (9) , 1411-1413
Open AccessThe Hidden Victims of the COVID-19 Pandemic
- 23 May 2019
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 95 (1) , 78-82
Transcatheter closure of residual patent ductus arteriosus
Introduction: Residual patent ductus arteriosus (rPDAs) can occur following surgical or transcatheter treatment, and are indicated for closure because of the risks of infective endarteritis and hemolysis in addition to the hemodynamic effect of the residual left‐to‐right shunt.Methods: This retrospective descriptive study describes our experience at two Egyptian centers (Cairo University Children's Hospital & Tanta University Hospital) with transcatheter treatment of rPDAs, from January 2009 to October 2017.Results: Twenty cases were treated: 17/20 postsurgical and 3/20 post‐transcatheter, at a mean period of 13.4 ± 9.3 months from the initial procedure. The median rPDA size was 2 mm (range2–3.5 mm). Most common ductal anatomy was the conical shape. All rPDAs were successfully closed with either coils (13/20) or devices (6/20), except one case where the residual flow was within the device mesh material. Coils could be deployed from the antegrade or the retrograde approaches although the latter was associated with a higher incidence of late shunt occlusion. One case with a malpositioned device required simultaneous device and LPA stent deployment.Conclusion: Transcatheter closure of rPDAs is feasible in most cases, but may be technically challenging.
- 23 May 2019
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 95 (1) , 78-82
Transcatheter closure of residual patent ductus arteriosus
Introduction: Residual patent ductus arteriosus (rPDAs) can occur following surgical or transcatheter treatment, and are indicated for closure because of the risks of infective endarteritis and hemolysis in addition to the hemodynamic effect of the residual left‐to‐right shunt.Methods: This retrospective descriptive study describes our experience at two Egyptian centers (Cairo University Children's Hospital & Tanta University Hospital) with transcatheter treatment of rPDAs, from January 2009 to October 2017.Results: Twenty cases were treated: 17/20 postsurgical and 3/20 post‐transcatheter, at a mean period of 13.4 ± 9.3 months from the initial procedure. The median rPDA size was 2 mm (range2–3.5 mm). Most common ductal anatomy was the conical shape. All rPDAs were successfully closed with either coils (13/20) or devices (6/20), except one case where the residual flow was within the device mesh material. Coils could be deployed from the antegrade or the retrograde approaches although the latter was associated with a higher incidence of late shunt occlusion. One case with a malpositioned device required simultaneous device and LPA stent deployment.Conclusion: Transcatheter closure of rPDAs is feasible in most cases, but may be technically challenging.
- 25 September 2012
- Published by Springer Nature in Comparative Clinical Pathology
- Vol. 23 (2) , 317-322
Maternal and offspring methylenetetrahydrofolate reductase gene C677T polymorphism: does it influence the prevalence of congenital heart defects in Egyptian neonates?
- 25 September 2012
- Published by Springer Nature in Comparative Clinical Pathology
- Vol. 23 (2) , 317-322
Maternal and offspring methylenetetrahydrofolate reductase gene C677T polymorphism: does it influence the prevalence of congenital heart defects in Egyptian neonates?